SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.75 CNY | +7.01% |
|
+4.06% | -23.57% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Shenzhen Kangtai Biological Products Co. specialises in the research, development and marketing of human vaccines. Products include vaccines against hepatitis B, haemophilus influenzae type B, measles and rubella.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
20.75
CNY
Average target price
37.75
CNY
Spread / Average Target
+81.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -23.57% | 2.99B | |
| -4.66% | 87.53B | |
| +1.32% | 40.42B | |
| -19.27% | 29.48B | |
| +57.86% | 25.43B | |
| -17.69% | 11.49B | |
| -43.00% | 11.3B | |
| -9.14% | 11.1B | |
| +5.24% | 8.75B | |
| -8.42% | 7.99B |
- Stock Market
- Equities
- 300601 Stock
- News Shenzhen Kangtai Biological Products Co., Ltd.
- Shenzhen Kangtai Biological Products : China Approves Kangtai Biological's COVID-19 Vaccine For Emergency Use
